LUMENENZ

Serial Number 85604172
606

Registration Progress

Application Filed
Apr 20, 2012
Under Examination
Nov 13, 2012
Approved for Publication
Sep 18, 2012
Published for Opposition
Sep 18, 2012
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: LUMENENZ
Previous Owner: Curemark, LLC
Classes: 005

Trademark Image

LUMENENZ

Basic Information

Serial Number
85604172
Filing Date
April 20, 2012
Published for Opposition
September 18, 2012
Abandonment Date
December 14, 2015
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 14, 2015
Classes
005

Rights Holder

Curemark, LLC

16
Address
411 Theodore Fremd Ave., Suite 206
Rye, NY 10580

Ownership History

Curemark, LLC

Original Applicant
16
Rye, NY

Curemark, LLC

Owner at Publication
16
Rye, NY

Legal Representation

Attorney
Nicole K. McLaughlin

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

41 events
Date Code Type Description Documents
Dec 14, 2015 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Dec 14, 2015 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 16, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 15, 2015 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 8, 2015 EXT5 S SOU EXTENSION 5 FILED Loading...
Apr 8, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 15, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 14, 2014 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 13, 2014 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 13, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 22, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 13, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
May 15, 2014 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
May 15, 2014 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
May 15, 2014 PETG O PETITION TO REVIVE-GRANTED Loading...
May 15, 2014 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Jan 3, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 6, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 31, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 10, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 6, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 1, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
May 1, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 13, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 18, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 18, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 29, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 14, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 14, 2012 ALIE A ASSIGNED TO LIE Loading...
Aug 3, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 3, 2012 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 3, 2012 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 3, 2012 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 3, 2012 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 1, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 27, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 24, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of pervasive development disorders, dysautonomias, topical infections, wounds, alopecia, celiac disease and influenza; pharmaceutical preparations for the treatment of microbial infections, including bacterial, viral and prion diseases; pharmaceutical preparations for the treatment of cystic fibrosis, pancreatic dysfunction and related disorders; pharmaceutical preparations for the treatment of neuropsychiatric and mental health disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005